Evidence map›Paper›PMID 33687588›Full record

ReviewMolecular and cellular biochemistry2021

Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy.

Fauzia Nazam, Sibhghatulla Shaikh, Nazia Nazam, Abdulaziz Saad Alshahrani, Gulam Mustafa Hasan, Md Imtaiyaz Hassan

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Molecular and cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06767410 (A Multi-domain Intervention to Constrast Cognitive Decline in Healthy Aging), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06767410 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Multi-domain Intervention to Constrast Cognitive Decline in Healthy Aging

TypeinterventionalSponsorUniversity of BariRan2025 to 2027Enrolled100ConditionsHealthy Volunteer StudyArmsMultidomain Intervention, General activities
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fauzia Nazam *Section of Psychology, Women's College, Aligarh Muslim University, Aligarh, UP, 202002, India.
Sibhghatulla Shaikh *Department of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Nazia NazamAmity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, 201313, India. nazianazam@gmail.com.
Abdulaziz Saad AlshahraniDepartment of Medicine, Najran University, P.O. Box- 1988, Najran, Saudi Arabia.
Gulam Mustafa HasanDepartment of Biochemistry, College of Medicine, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj, 11942, Kingdom of Saudi Arabia.
Md Imtaiyaz HassanCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India. mihassan@jmi.ac.in.ORCID http://orcid.org/0000-0002-3663-4940

Funding

National Medicinal Plants Board, Ministry of AYUSH, Government of India Z. 18017/187/CSS/R&D/DL-01/2019-20-NMPB-IVA
6 · The paper itself

Abstract

Neurodegeneration is a prevalent and one of the emerging reasons for morbidity, mortality, and cognitive impairment in aging. Dementia is one of such conditions of neurodegeneration, partially manageable, irreversible, and worsens over time. This review is focused on biological and psychosocial risk factors associated with Alzheimer's and Parkinson's diseases, highlighting the value of cognitive decline. We further emphasized on current therapeutic strategies from pharmacological and non-pharmacological perspectives focusing on their effects on cognitive impairment, protein aggregation, tau pathology, and improving the quality of life. Deeper mechanistic insights into the multifactorial neurodegeneration could offer the design and development of promising diagnostic and therapeutic strategies.

Indexed as

Alzheimer DiseaseCognitive DysfunctionParkinson DiseaseAnimalsHumansAlzheimer’s disease; Parkinson’s diseaseNeurodegenerationNeurodegenerative diseasesTherapeutic management

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.